TipRanks
Advertisement
Advertisement
Insmed announces Japan’s MHLW approves Brinsupri
PremiumThe FlyInsmed announces Japan’s MHLW approves Brinsupri
22d ago
Insmed Earnings Call Highlights BRINSUPRI-Driven Surge
Premium
Company Announcements
Insmed Earnings Call Highlights BRINSUPRI-Driven Surge
29d ago
Analyst Maintains Buy/Overweight Rating and $218 Price Target on Brinsupri’s Strong Q2 Outperformance
Premium
Ratings
Analyst Maintains Buy/Overweight Rating and $218 Price Target on Brinsupri’s Strong Q2 Outperformance
29d ago
Insmed price target raised to $170 from $160 at Evercore ISI
PremiumThe FlyInsmed price target raised to $170 from $160 at Evercore ISI
1M ago
Insmed price target lowered to $205 from $207 at Guggenheim
Premium
The Fly
Insmed price target lowered to $205 from $207 at Guggenheim
1M ago
Insmed price target raised to $172 from $166 at UBS
Premium
The Fly
Insmed price target raised to $172 from $166 at UBS
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100